Watch the interview with Dr. Peter H. Diamandis, Founder and Executive Chairman of the XPRIZE Foundation, as we explore the outlook for longevity clinics in 2026, the role of AI in healthcare, and the technologies shaping the future of human longevity.
This conversation took place during the Roundtable for Longevity Clinics 2025, organised by the International Institute of Longevity, held at the Buck Institute for Research on Aging, where global leaders came together to discuss what’s next for longevity medicine, innovation, and scalable impact.
KEY TAKEWAYS:
Dr. Diamandis presents a future where AI, deep diagnostics, and regenerative medicine converge to move humanity beyond healthspan optimization toward true age reversal. Longevity centers will serve as high-tech hubs for diagnostics and advanced therapies, while AI companions provide continuous, personalized care fundamentally redefining medicine, aging, and the role of the physician.
Dr. Peter Diamandis emphasizes that the longevity sector is entering a new phase of credibility and momentum, driven primarily by advances in artificial intelligence. He notes that longevity is no longer seen as speculative or aspirational, but as a technology-enabled, data-driven field with real potential to extend human healthspan and eventually also lifespan.
